Platelet-derived Evs
Platelet-derived Evs - Related Videos
04:56
Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
0 Views •
2023
This protocol investigates the use of extracellular vesicle (EV)-rich plasma as an indicator of the coagulative ability of EV. EV-rich plasma is obtained through a process of differential centrifugation and subsequent recalcification.
09:13
Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
0 Views •
Cited by 5 •
2017
We describe a straightforward method for the isolation of washed platelets from human blood followed by agonist-induced platelet aggregation measurements by turbidimetry. As an example we apply this method for studying the aggregation response of human platelets to collagen after a pre-incubation with the Pannexin1 channel inhibitor Brilliant Blue FCF.
05:07
An In Vitro Method for the Differentiation of Megakaryocytes and Platelet Formation
0 Views •
2025
This video demonstrates a technique for the differentiation of megakaryocytes and the formation of platelets. Hematopoietic stem progenitor cells — isolated from human umbilical cord blood — differentiate into mature megakaryocytes in the presence of thrombopoietin. The mature megakaryocytes produce cytoplasmic extensions termed proplatelets, which give rise to individual platelets.
07:33
Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
0 Views •
2025
The therapeutic application of extracellular vesicles (EVs) has the potential to revolutionize cancer treatment and drug delivery. Chimeric antigen receptor (CAR) cell-derived EVs (CAR-EVs) isolated using ion-exchange chromatography exhibit increased cargo capacity, significantly enhancing their functional efficacy. This study further characterizes CAR-EVs to elucidate their biological activity and therapeutic potential.
06:04
LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism
0 Views •
Cited by 7 •
2016
Here we show isolated human platelets can be used as an accessible ex vivo model to study metabolic adaptations in response to the complex I inhibitor rotenone. This approach employs isotopic tracing and relative quantification by liquid chromatography-mass spectrometry and can be applied to a variety of study designs.
FAQs
Formation depends on reorganization of the platelet membrane together with cytoskeletal remodeling. These changes promote outward budding, allowing portions of the platelet membrane to enclose selected proteins, lipids, and nucleic acids. The resulting vesicles preserve a membrane-based interface that can later interact with recipient cells, making structural remodeling central to both vesicle production and biological signaling.
Platelet-derived EVs can originate from activated or resting platelets, so the platelet state is an important variable when interpreting their composition and function. Activation-related changes in membrane organization may affect vesicle formation and the signals enclosed or displayed. Consequently, activation state can influence how these vesicles are studied as mediators of vascular and immune regulation or as indicators of platelet activity.
Surface components provide the external features through which platelet-derived EVs interact with recipient cells. These interactions help transfer biological signals and may influence vascular, immune, or tissue responses. In bioengineering, the same surface characteristics are valuable because they can support communication with cells and contribute to the design of carriers intended to deliver biological cargo or shape regenerative responses.
Unlike signals that are not enclosed by a membrane, platelet-derived EVs package proteins, lipids, and nucleic acids inside membrane-bound particles. This organization creates a distinct transport format for biological information and presents surface components to recipient cells. The combination of enclosed cargo and an interactive membrane makes these vesicles relevant to engineered delivery systems as well as natural vascular and immune communication.
Studies should account for whether the vesicles arise from activated or resting platelets and examine their membrane organization, surface components, and enclosed proteins, lipids, and nucleic acids. These features help connect vesicle structure with biological activity. Evaluating them is relevant when developing platelet-derived EVs as carriers, biomaterial components, or tools for studying platelet activation and vascular conditions.
They are relevant when a naturally sourced, membrane-bound carrier is being investigated for interaction with recipient cells and transfer of biological signals. Their surface components can support cell communication, while their enclosed cargo provides a basis for delivery-oriented designs. In regenerative medicine and biomaterial research, these properties are examined for their potential to influence tissue responses rather than merely transport isolated molecules.
Platelet-derived EVs provide measurable information about platelet activation and vascular conditions because their presence and properties reflect platelet-related membrane changes and signaling activity. Researchers can therefore examine them as biological indicators alongside their functional roles. This dual value connects bioengineering studies of vesicle design with investigations of vascular regulation and the cellular responses associated with platelet activity.